ATE429916T1 - Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme - Google Patents
Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahmeInfo
- Publication number
- ATE429916T1 ATE429916T1 AT02783922T AT02783922T ATE429916T1 AT E429916 T1 ATE429916 T1 AT E429916T1 AT 02783922 T AT02783922 T AT 02783922T AT 02783922 T AT02783922 T AT 02783922T AT E429916 T1 ATE429916 T1 AT E429916T1
- Authority
- AT
- Austria
- Prior art keywords
- food consumption
- treating obesity
- sulfonamide derivatives
- reducing food
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103767A SE0103767D0 (sv) | 2001-11-09 | 2001-11-09 | New use |
US35689002P | 2002-02-13 | 2002-02-13 | |
PCT/SE2002/002019 WO2003039547A1 (en) | 2001-11-09 | 2002-11-06 | Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE429916T1 true ATE429916T1 (de) | 2009-05-15 |
Family
ID=26655592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02783922T ATE429916T1 (de) | 2001-11-09 | 2002-11-06 | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030166663A1 (de) |
EP (1) | EP1450806B1 (de) |
JP (1) | JP2005511594A (de) |
AT (1) | ATE429916T1 (de) |
DE (1) | DE60232173D1 (de) |
WO (1) | WO2003039547A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1897881A3 (de) * | 2002-06-20 | 2009-03-18 | Biovitrum AB (publ) | Zur Behandlung von Obesitas, Typ II-Diabetes und ZNS-Erkrankungen geeignete Verbindungen |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
ES2228267B1 (es) * | 2003-07-30 | 2006-07-01 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6. |
ES2228268B1 (es) * | 2003-07-30 | 2006-07-01 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6. |
EP2305352A1 (de) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | 5-alpha-Reduktaseinhibitoren zur Behandlung von Stoffwechsel- und anthropometrischen Störungen |
WO2006047302A1 (en) * | 2004-10-21 | 2006-05-04 | Transtech Pharma, Inc. | Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
WO2007004959A1 (en) * | 2005-07-05 | 2007-01-11 | Astrazeneca Ab | New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
WO2007004960A1 (en) * | 2005-07-05 | 2007-01-11 | Astrazeneca Ab | New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer’s desease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson’s disease |
JP4434182B2 (ja) | 2006-07-25 | 2010-03-17 | セイコーエプソン株式会社 | 眼鏡レンズの設計方法 |
MX2009013293A (es) | 2007-06-04 | 2010-02-15 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos. |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
ES2627848T3 (es) | 2008-06-04 | 2017-07-31 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CN108676076A (zh) | 2011-03-01 | 2018-10-19 | 辛纳吉制药公司 | 制备鸟苷酸环化酶c激动剂的方法 |
JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
KR102272746B1 (ko) | 2013-06-05 | 2021-07-08 | 보슈 헬스 아일랜드 리미티드 | 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT689536E (pt) | 1993-03-16 | 2001-11-30 | Pfizer | Derivados de naftaleno |
DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
GB9803411D0 (en) * | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
WO1999044609A1 (en) * | 1998-03-03 | 1999-09-10 | Merck & Co., Inc. | FUSED PIPERIDINE SUBSTITUTED ARYLSULFONAMIDES AS β3-AGONISTS |
TWI222450B (en) * | 1999-07-28 | 2004-10-21 | Upjohn Co | Oxazinocarbazoles for the treatment of CNS diseases |
GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
US6399617B1 (en) * | 2000-07-21 | 2002-06-04 | Biovitrum Ab | Use |
-
2002
- 2002-11-06 DE DE60232173T patent/DE60232173D1/de not_active Expired - Fee Related
- 2002-11-06 EP EP02783922A patent/EP1450806B1/de not_active Expired - Lifetime
- 2002-11-06 JP JP2003541838A patent/JP2005511594A/ja active Pending
- 2002-11-06 WO PCT/SE2002/002019 patent/WO2003039547A1/en active Application Filing
- 2002-11-06 AT AT02783922T patent/ATE429916T1/de not_active IP Right Cessation
- 2002-11-08 US US10/290,915 patent/US20030166663A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2005511594A (ja) | 2005-04-28 |
WO2003039547A1 (en) | 2003-05-15 |
EP1450806A1 (de) | 2004-09-01 |
US20030166663A1 (en) | 2003-09-04 |
EP1450806B1 (de) | 2009-04-29 |
DE60232173D1 (de) | 2009-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE429916T1 (de) | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme | |
ATE353646T1 (de) | Verwendung von indol- und indolin-derivaten bei der behandlung von adipositas oder zur reduzierung der nahrungsaufnahme | |
TW200510334A (en) | Preraration and use of aryl alkyl acid derivatives for the treatment of obesity | |
ATE388951T1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
NO20065079L (no) | Materialer og metoder for behandling av koaguleringssykdommer | |
DE602006010442D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen | |
EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
EA200802329A1 (ru) | Производные триазола ii | |
DE602006020775D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von manie und bipolaren störungen | |
DE502004006619D1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
MY145823A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity | |
ATE464895T1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen | |
BR0309342A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
ATE373474T1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
ATE384058T1 (de) | Thiazolderivate | |
ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
BRPI0416030A (pt) | pirido-7-pirimidin-7-onas substituìdas com hidroxialquila | |
DE602005014632D1 (de) | Pyrrol- bzw. imidazolamide zur behandlung von obesitas | |
EA200501310A1 (ru) | Производные бензолсульфонамидов, способ их получения и их применение для лечения боли | |
ATE267597T1 (de) | Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas | |
SE0002739D0 (sv) | New use | |
MXPA05007715A (es) | Derivados de carboxamida y uso de los mismos como inhibidores del factor xa. | |
DE602004024871D1 (de) | Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten | |
EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
ATE423780T1 (de) | Makrozyclen zur behandlung von krebserkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |